World bleeding disorders registry: The pilot study

被引：17

作者：

Coffin, D. ^{[1
]}

Herr, C. ^{[1
]}

O'Hara, J. ^{[2
]}

Diop, S. ^{[3
]}

Hollingsworth, R. ^{[4
]}

Srivastava, A. ^{[5
]}

Lillicrap, D. ^{[6
]}

van den Berg, H. M. ^{[7
]}

Iorio, A. ^{[8
]}

Pierces, G. F. ^{[1
]}

机构：

[1] World Federat Hemophilia, Montreal, PQ, Canada

[2] HCD Econ, Manchester, Lancs, England

[3] Cheikh Anta Diop Univ, Dakar, Senegal

[4] Med Data Solut & Serv MDSAS, Manchester, Lancs, England

[5] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India

[6] Queens Univ, Kingston, ON, Canada

[7] Univ Med Ctr, Utrecht, Netherlands

[8] McMaster Univ, Hamilton, ON, Canada

来源：

HAEMOPHILIA | 2018年 / 24卷 / 03期

关键词：

FACTOR-VIII INHIBITORS; HEMOPHILIA-A PATIENTS; NIJMEGEN MODIFICATION; DEFICIENT PLASMA; BETHESDA ASSAY; ALBUMIN;

D O I：

10.1111/hae.13431

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E113 / E116

页数：4

共 10 条

[1] Definitions in hemophilia: communication from the SSC of the ISTH
Blanchette, V. S.
Key, N. S.
Ljung, L. R.
Manco-Johnson, M. J.
Van Den Berg, H. M.
Srivastava, A.
[J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (11) : 1935 - 1939
[2] Validation of 4% albumin as a diluent in the Bethesda Assay for FVIII inhibitors
Kershaw, Geoffrey W.
Chen, Lin S.
Jayakodi, Dayani
Dunkley, Scott M.
[J]. THROMBOSIS RESEARCH, 2013, 132 (06) : 735 - 741
[3] Limit of detection and threshold for positivity of the Centers for Disease Control and Prevention assay for factor VIII inhibitors
Miller, C. H.
Boylan, B.
Shapiro, A. D.
Lentz, S. R.
Wicklund, B. M.
[J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (10) : 1971 - 1976
[4] Validation of Nijmegen-Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance
Miller, C. H.
Platt, S. J.
Rice, A. S.
Kelly, F.
Soucie, J. M.
[J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (06) : 1055 - 1061
[5] Laboratory Assessment of Factor VIII Inhibitor Titer The North American Specialized Coagulation Laboratory Association Experience
Peerschke, Ellinor I. B.
Castellone, Donna D.
Ledford-Kraemer, Marlies
Van Cott, Elizabeth M.
Meijer, Piet
[J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 131 (04) : 552 - 558
[6] Does the presence of von Willebrand factor in FVIII-deficient plasma influences the measurement of FVIII inhibitor titres in haemophilia A patients?
Pouplard, C.
Desconclois, C.
Sobas, F.
Aillaud, M. F.
Ternisien, C.
Caron, C.
[J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2015, 37 (01) : 125 - 132
[7] VERBRUGGEN B, 1995, THROMB HAEMOSTASIS, V73, P247
[8] Verbruggen B, 2002, THROMB HAEMOSTASIS, V88, P362
[9] Verbruggen B, 2001, THROMB HAEMOSTASIS, V86, P1435
[10] Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients
Whelan, Shawn F. J.
Hofbauer, Christoph J.
Horling, Frank M.
Allacher, Peter
Wolfsegger, Martin J.
Oldenburg, Johannes
Male, Christoph
Windyga, Jerzy
Tiede, Andreas
Schwarz, Hans Peter
Scheiflinger, Friedrich
Reipert, Birgit M.
[J]. BLOOD, 2013, 121 (06) : 1039 - 1048

← 1 →